Xin Guo Selected Research

apigenin-7-O-glucuronide

11/2020

A sensitive ultra-fast liquid chromatography with tandem mass spectrometry method for simultaneous determination of ten constituents of Deng-Zhan-Xi-Xin injection in rat plasma and its application to a comparative pharmacokinetic study in sham and middle cerebral artery occlusion rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Guo Research Topics

Disease

97	Neoplasms (Cancer) 08/2022 - 01/2006
47	Inflammation (Inflammations) 04/2022 - 06/2005
40	Infections 10/2022 - 05/2004
16	Non-alcoholic Fatty Liver Disease 10/2021 - 08/2010
15	Insulin Resistance 04/2022 - 02/2010
15	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2006
13	Atherosclerosis 01/2022 - 04/2011
12	Fibrosis (Cirrhosis) 12/2022 - 12/2013
12	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 08/2012
11	Carcinogenesis 01/2022 - 03/2008
11	Ischemia 01/2022 - 01/2005
11	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2013
11	Obesity 01/2021 - 12/2012
10	Wounds and Injuries (Trauma) 01/2022 - 09/2002
9	Reperfusion Injury 07/2022 - 10/2017
9	Adenocarcinoma 04/2022 - 11/2011
8	Stroke (Strokes) 01/2022 - 01/2005
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 01/2017
7	Type 2 Diabetes Mellitus (MODY) 07/2021 - 12/2013
7	Virus Diseases (Viral Diseases) 07/2021 - 03/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 01/2016
6	Infarction (Infarctions) 07/2022 - 01/2007
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 12/2013
6	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2015
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2013
6	Hyperlipidemias (Hyperlipidemia) 01/2018 - 08/2010
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022 - 01/2005
5	Ischemic Stroke 07/2022 - 01/2016
5	Stomach Neoplasms (Stomach Cancer) 04/2022 - 03/2017
5	Hemorrhage 01/2022 - 04/2013
5	Myocardial Infarction 08/2021 - 08/2012
5	Hypertrophy 01/2021 - 01/2014
5	Heart Failure 01/2021 - 12/2009
5	Carcinoma (Carcinomatosis) 01/2021 - 05/2012
5	Esophageal Neoplasms (Esophageal Cancer) 03/2018 - 01/2015
4	Hyperglycemia 04/2022 - 07/2010
4	Diarrhea 02/2022 - 01/2017
4	Edema (Dropsy) 01/2022 - 01/2018
4	Body Weight (Weight, Body) 01/2022 - 12/2016
4	Cysts 07/2021 - 07/2017
4	Hyperplasia 03/2021 - 02/2013
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 03/2017
4	Bites and Stings (Sting) 01/2021 - 10/2011
4	Cardiotoxicity 06/2018 - 07/2014
4	Atherosclerotic Plaque (Atheroma) 03/2017 - 07/2011
4	Esophageal Squamous Cell Carcinoma 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

60	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
20	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 12/2007
18	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2012
17	CytokinesIBA 10/2022 - 01/2010
16	Pharmaceutical PreparationsIBA 12/2022 - 07/2006
15	Messenger RNA (mRNA)IBA 02/2022 - 05/2007
14	EnzymesIBA 01/2022 - 08/2010
13	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2015
12	LipidsIBA 03/2022 - 12/2012
11	Biological ProductsIBA 03/2022 - 01/2015
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2012
10	PeroxiredoxinsIBA 01/2020 - 11/2012
9	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2008
9	CholesterolIBA 06/2020 - 08/2010
8	VaccinesIBA 10/2022 - 12/2006
8	Liposomes (Liposome)IBA 03/2022 - 01/2007
8	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 07/2014
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2007
7	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 10/2007
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2017
7	IronIBA 01/2022 - 08/2011
7	AntioxidantsIBA 01/2021 - 10/2015
6	NF-kappa B (NF-kB)IBA 01/2022 - 05/2004
6	Capsules (Microcapsules)IBA 03/2021 - 07/2006
6	Phosphotransferases (Kinase)IBA 01/2021 - 03/2016
6	salicylhydroxamic acid (SHAM)IBA 11/2020 - 10/2017
6	Therapeutic UsesIBA 05/2020 - 06/2010
6	Long Noncoding RNAIBA 01/2020 - 01/2016
6	CollagenIBA 01/2019 - 11/2012
6	ApolipoproteinsIBA 02/2017 - 04/2011
6	Histamine (Histamine Dihydrochloride)FDA Link 07/2016 - 08/2010
5	Apolipoproteins E (ApoE)IBA 01/2022 - 04/2011
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
5	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2017
5	Streptozocin (Streptozotocin)FDA Link 11/2021 - 11/2010
5	Amino Acids FDA Link 10/2021 - 06/2011
5	Insulin (Novolin)FDA Link 01/2021 - 05/2013
5	DysbindinIBA 01/2021 - 10/2016
5	oxidized low density lipoproteinIBA 01/2018 - 07/2015
5	AlginatesIBA 01/2016 - 07/2006
4	LipopolysaccharidesIBA 04/2022 - 05/2014
4	Toll-Like Receptor 4IBA 11/2021 - 01/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 05/2004
4	AntigensIBA 07/2021 - 05/2015
4	Hormones (Hormone)IBA 01/2021 - 09/2013
4	SuspensionsIBA 07/2020 - 01/2014
4	7-O-geranylquercetinIBA 12/2019 - 12/2015
4	Interferon Type IIBA 09/2019 - 08/2014
4	LDL Receptors (LDL Receptor)IBA 01/2018 - 07/2015

Therapy/Procedure

37	Therapeutics 07/2022 - 01/2006
15	Drug Therapy (Chemotherapy) 04/2022 - 07/2014
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2022 - 07/2013
7	Transplantation 11/2022 - 05/2007
4	Radiotherapy 01/2021 - 10/2018